Following Stent Placement, Low Platelet Reactivity at Time of Discharge and After 30 Days Leads to 50% Reduction in Cardiovascular Events

SAN DIEGO, CA – Data announced today at the European Society of Cardiology (ESC) Congress in Paris and simultaneously published in Circulation1 show that stent patients exhibited a 50% reduction in cardiovascular death, heart attack and stent thrombosis over 6 months when they achieved low platelet reactivity, as measured by the Accumetrics’ VerifyNow P2Y12 Test, at discharge and 30 days post-procedure. The VerifyNow P2Y12 Test is used to measure a patient’s platelet reactivity and the antiplatelet effect of medications such as clopidogrel or prasugrel (Plavix® and Effient®). Read More…

August 16 groundbreaking celebrated for 50-bed, 50,000-square-foot facility

NASHVILLE, TENNESSEE and OKLAHOMA CITY, OKLAHOMA – Mercy Health Center, in partnership with Nashville based Centerre Healthcare Corporation – a national leader in the development and operation of rehabilitation hospitals, broke ground this past Tuesday for the construction of the 50,000-square-foot comprehensive Mercy Rehabilitation Hospital. Read More…

Construction to begin October 2011

CLEVELAND, OH and NASHVILLE, TN – University Hospitals (UH) in Cleveland, OH, and Nashville-based Centerre Healthcare Corporation announced today a joint venture to construct a comprehensive inpatient rehabilitation hospital in Beachwood, OH. Read More…

Cleveland, OH – JumpStart, a nonprofit that invests in and assists high growth, early stage companies in Northeast Ohio, and RiverVest Venture Partners, a venture capital firm focused on early stage life science companies, announced a co-investment of $750,000 in Securus Medical Group. Read More…